Lori Youmshajekian June 06, 2023 The US Food and Drug Administration (FDA) has approved an injectable hyaluronic acid dermal filler for improvement of infraorbital hollowing, the manufacturer announced in a press release. The product, which will be marketed by Galderma as Restylane Eyelight, is indicated for volume loss under the eyes in patients older than 21 years. The...
